Loading
A phase 2 trial of adebrelimab in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting.
A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations is a phase 2, randomised interventional study registered as NCT07824882 by Hansoh BioMedical R&D Company, with a registry enrolment figure of 76 participants, started 2026-09-10 and due to reach its primary completion in 2028-03-30. Interventions recorded: HS-20093 for Injection; Adebrelimab Injection. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: Objective Response Rate (ORR); Progression-Free Survival (PFS). Lung eligibility wording from the registry: "Previously treated patients with histologically or cytologically confirmed diagnosis of advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC)". No results are recorded here; the registry entry is the source.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.
Shares Hansoh Pharmaceutical, Adebrelimab, Lung cancer trials open today (registry snapshot), Immune checkpoint inhibitors and the tag lung-deep-dive.